- Home
- AXG vs KOD Comparison
AXG vs KOD Comparison
Compare AXG & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXG
- KOD
- Stock Information
- Founded
- AXG 2021
- KOD 2009
- Country
- AXG Hong Kong
- KOD United States
- Employees
- AXG N/A
- KOD N/A
- Industry
- AXG Investment Bankers/Brokers/Service
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXG Finance
- KOD Health Care
- Exchange
- AXG Nasdaq
- KOD Nasdaq
- Market Cap
- AXG 692.6M
- KOD 795.5M
- IPO Year
- AXG 2023
- KOD 2018
- Fundamental
- Price
- AXG $3.37
- KOD $17.63
- Analyst Decision
- AXG
- KOD Buy
- Analyst Count
- AXG 0
- KOD 7
- Target Price
- AXG N/A
- KOD $19.29
- AVG Volume (30 Days)
- AXG 1.0M
- KOD 981.7K
- Earning Date
- AXG 06-30-2025
- KOD 11-13-2025
- Dividend Yield
- AXG N/A
- KOD N/A
- EPS Growth
- AXG N/A
- KOD N/A
- EPS
- AXG N/A
- KOD N/A
- Revenue
- AXG $3,316,000.00
- KOD N/A
- Revenue This Year
- AXG $28.53
- KOD N/A
- Revenue Next Year
- AXG $54.60
- KOD N/A
- P/E Ratio
- AXG N/A
- KOD N/A
- Revenue Growth
- AXG N/A
- KOD N/A
- 52 Week Low
- AXG $2.91
- KOD $1.92
- 52 Week High
- AXG $4.17
- KOD $21.17
- Technical
- Relative Strength Index (RSI)
- AXG N/A
- KOD 51.91
- Support Level
- AXG N/A
- KOD $17.04
- Resistance Level
- AXG N/A
- KOD $19.26
- Average True Range (ATR)
- AXG 0.00
- KOD 1.82
- MACD
- AXG 0.00
- KOD -0.34
- Stochastic Oscillator
- AXG 0.00
- KOD 22.24
About AXG Solowin Holdings Class A Ordinary Share
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.